6039
Japan Animal Referral Medical Center Co.,Ltd.
日本動物高度医療センター
- Industry
- Services
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
2,847,833
Mar 2022
2,979,011
Mar 2023
3,872,994
Mar 2024
4,270,195
Mar 2025
5,277,736
Operating profit(thousand JPY)
Mar 2021
405,543
Mar 2022
439,236
Mar 2023
580,548
Mar 2024
496,919
Mar 2025
720,974
Operating profit margin(%)
Mar 2021
14.24
Mar 2022
14.74
Mar 2023
14.99
Mar 2024
11.64
Mar 2025
13.66
Profit before tax(thousand JPY)
Mar 2021
411,995
Mar 2022
423,583
Mar 2023
533,932
Mar 2024
491,305
Mar 2025
720,263
Profit(thousand JPY)
Mar 2021
285,190
Mar 2022
286,939
Mar 2023
380,664
Mar 2024
337,217
Mar 2025
520,982
Total assets(thousand JPY)
Mar 2021
5,844,116
Mar 2022
6,966,910
Mar 2023
8,578,896
Mar 2024
8,770,036
Mar 2025
8,753,719
Cash and cash equivalents(thousand JPY)
Mar 2021
1,114,671
Mar 2022
968,595
Mar 2023
1,816,039
Mar 2024
1,337,639
Mar 2025
1,107,603
Cash flows from operating activities(thousand JPY)
Mar 2021
504,393
Mar 2022
557,574
Mar 2023
810,922
Mar 2024
899,782
Mar 2025
1,372,376
Cash flows from investing activities(thousand JPY)
Mar 2021
-69,570
Mar 2022
-1,425,741
Mar 2023
-784,065
Mar 2024
-985,860
Mar 2025
-994,383
Cash flows from financing activities(thousand JPY)
Mar 2021
-469,428
Mar 2022
722,091
Mar 2023
820,586
Mar 2024
-392,322
Mar 2025
-608,029
Return on equity(%)
Mar 2021
12.8
Mar 2022
11.8
Mar 2023
12.2
Mar 2024
9
Mar 2025
13.1
Equity ratio(%)
Mar 2021
40
Mar 2022
36
Mar 2023
43.2
Mar 2024
43.5
Mar 2025
47.4
Earnings per share(JPY per share)
Mar 2021
120.73
Mar 2022
120.95
Mar 2023
156.33
Mar 2024
123.01
Mar 2025
201.12
Net assets per share(JPY per share)
Mar 2021
981.33
Mar 2022
1,078.8
Mar 2023
1,354.99
Mar 2024
1,446.52
Mar 2025
1,604.99
Dividend per share(JPY per share)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
20
Mar 2025
37
Payout ratio(%)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
16.26
Mar 2025
18.4
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.